Establishing a Biological Profile for Interval Colorectal Cancers

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2014 May 21

PMID 24839919

Citations 9

Authors

Amy L Cisyk

Harminder Singh

Kirk J McManus

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths in North America. Screening for CRC and its precursor lesions is highly effective in reducing the incidence and deaths due to the disease. However, there remain a substantial number of individuals who are diagnosed with CRC soon after a negative/clearing colonoscopy with no documented evidence of CRC. The occurrence of these interval CRCs (I-CRCs) reduces the effectiveness of CRC screening and detection tests and has only recently attracted wide spread attention. I-CRCs can be subdivided into those that occur most likely due to the failure of the colonoscopy examination (missed CRC and CRC that developed from missed or incompletely resected precursor lesions) and those that develop rapidly after the colonoscopy (de novo I-CRCs). In this review, we discuss the current literature and present both the clinical and biological factors that have been identified to account for I-CRCs, with a particular focus on the aberrant molecular features that are candidate causative agents for I-CRCs. We conclude additional studies are required to fully understand the molecular features that lead to the development of I-CRCs, which in turn is essential to develop measures to prevent the occurrence of this group of CRCs and thereby improve CRC screening and detection strategies.

Citing Articles

Postcolonoscopy Colorectal Cancer in a Referral Center for Colorectal Cancer: Prevalence and Risk Factors.

Goncalves M, Silva J, Carvalho T, Costa D, Goncalves R, Rebelo A GE Port J Gastroenterol. 2023; 30(5):359-367.

PMID: 37868634 PMC: 10586210. DOI: 10.1159/000526126.

The impact of surgical weight loss procedures on the risk of metachronous colorectal neoplasia: the differential effect of surgery type, sex, and anatomic location.

Hussan H, Ali M, Hussain S, Lyo V, McLaughlin E, Chiang C J Natl Cancer Inst Monogr. 2023; 2023(61):77-83.

PMID: 37139983 PMC: 10157775. DOI: 10.1093/jncimonographs/lgac029.

Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study.

Bogie R, le Clercq C, Voorham Q, Cordes M, Sie D, Rausch C Br J Cancer. 2021; 126(6):865-873.

PMID: 34912077 PMC: 8927607. DOI: 10.1038/s41416-021-01619-z.

The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes.

Hussan H, Drosdak A, Le Roux M, Patel K, Porter K, Clinton S Obes Surg. 2019; 30(2):407-415.

PMID: 31646474 DOI: 10.1007/s11695-019-04176-w.

Adenoma miss rate of polypectomy-referring hospitals is high in Korea.

Seo J, Lee B, Lee K, Park J, Kim J, Cho Y Korean J Intern Med. 2019; 35(4):881-888.

PMID: 31610632 PMC: 7373960. DOI: 10.3904/kjim.2018.099.

References

Rex D, Petrini J, Baron T, Chak A, Cohen J, Deal S . Quality indicators for colonoscopy. Am J Gastroenterol. 2006; 101(4):873-85. DOI: 10.1111/j.1572-0241.2006.00673.x. View

Kambara T, Simms L, Whitehall V, Spring K, Wynter C, Walsh M . BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004; 53(8):1137-44. PMC: 1774130. DOI: 10.1136/gut.2003.037671. View

Singh H, Nugent Z, Demers A, Bernstein C . Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010; 105(12):2588-96. DOI: 10.1038/ajg.2010.390. View

Issa J, Vertino P, Wu J, Sazawal S, Celano P, Nelkin B . Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst. 1993; 85(15):1235-40. DOI: 10.1093/jnci/85.15.1235. View

Gafa R, Maestri I, Matteuzzi M, Santini A, Ferretti S, Cavazzini L . Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer. 2000; 89(10):2025-37. View

Robertson D, Greenberg E, Beach M, Sandler R, Ahnen D, Haile R . Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005; 129(1):34-41. DOI: 10.1053/j.gastro.2005.05.012. View

Issa J . CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004; 4(12):988-93. DOI: 10.1038/nrc1507. View

Shaukat A, Arain M, Anway R, Manaktala S, Pohlman L, Thyagarajan B . Is KRAS mutation associated with interval colorectal cancers?. Dig Dis Sci. 2011; 57(4):913-7. DOI: 10.1007/s10620-011-1974-6. View

Torlakovic E, Skovlund E, Snover D, Torlakovic G, Nesland J . Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2002; 27(1):65-81. DOI: 10.1097/00000478-200301000-00008. View

10.

Herman J, Umar A, Polyak K, Graff J, Ahuja N, Issa J . Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998; 95(12):6870-5. PMC: 22665. DOI: 10.1073/pnas.95.12.6870. View

11.

Kawabata Y, Tomita N, Monden T, Ohue M, Ohnishi T, Sasaki M . Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int J Cancer. 1999; 84(1):33-8. DOI: 10.1002/(sici)1097-0215(19990219)84:1<33::aid-ijc7>3.0.co;2-z. View

12.

Meissner H, Breen N, Klabunde C, Vernon S . Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006; 15(2):389-94. DOI: 10.1158/1055-9965.EPI-05-0678. View

13.

Lurje G, Zhang W, Lenz H . Molecular prognostic markers in locally advanced colon cancer. Clin Colorectal Cancer. 2007; 6(10):683-90. DOI: 10.3816/CCC.2007.n.037. View

14.

Samowitz W, Sweeney C, Herrick J, Albertsen H, Levin T, Murtaugh M . Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005; 65(14):6063-9. DOI: 10.1158/0008-5472.CAN-05-0404. View

15.

Hewitson P, Glasziou P, Watson E, Towler B, Irwig L . Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008; 103(6):1541-9. DOI: 10.1111/j.1572-0241.2008.01875.x. View

16.

Konishi M, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N . Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology. 1996; 111(2):307-17. DOI: 10.1053/gast.1996.v111.pm8690195. View

17.

Martinez M, Baron J, Lieberman D, Schatzkin A, Lanza E, Winawer S . A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009; 136(3):832-41. PMC: 3685417. DOI: 10.1053/j.gastro.2008.12.007. View

18.

Esteller M . Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007; 16 Spec No 1:R50-9. DOI: 10.1093/hmg/ddm018. View

19.

Samowitz W, Holden J, Curtin K, Edwards S, Walker A, Lin H . Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol. 2001; 158(4):1517-24. PMC: 1891913. DOI: 10.1016/S0002-9440(10)64102-8. View

20.

Cunningham J, Christensen E, Tester D, Kim C, Roche P, Burgart L . Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998; 58(15):3455-60. View